Immugenia Inc
Immugenia Inc. is a preclinical stage immuno-oncology company developing the next generation CAR therapy to treat and prevent relapses in hematological and solid tumors. This is achieved by engineering hematopoietic stem cells using proprietary specific promoters (SPICA) to express CAR in select immune cells leveraging the synergistic activity of T and NK cells. This provides patients with a one-and-done treatment to fight hard-to-treat cancers and prevent relapses.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Immugenia Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- KB
Kathie Beland
Research Director · Research & Development
EmailPhone - SG
Stéphane Gagné
Founder, President & CEO · General Business & Management
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Immugenia Inc
2 distinct titles indexed · top 2 shown.
- 1founder, president & ceo
- 1research director
Sign up to unlock all 2 contacts at Immugenia Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Immugenia Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.